Pathogenetic Aspects of Preventive Correction of Cognitive Impairment in Metabolic Syndrome

Pathogenetic Aspects of Preventive Correction of Cognitive Impairment in Metabolic Syndrome

Objective. To study the opportunities to increase the efficiency of pathogenetic therapy in patients with chronic cerebrovascular diseases (CVD) (discirculatory encephalopathy, DE) on the background of metabolic syndrome (MS) using the drug Vitaxon®. The feature of the work was to identify strategic...

Full description

Bibliographic Details
Main Author: T.I. Nasonova
Format: Article
Language:English
Published: Publishing House Zaslavsky 2016-02-01
Series:Mìžnarodnij Endokrinologìčnij Žurnal
Subjects:
metabolic syndrome
discirculatory encephalopathy
treatment
Vitaxon®.
Online Access:http://iej.zaslavsky.com.ua/article/view/71069

Internet

http://iej.zaslavsky.com.ua/article/view/71069

Similar Items